our results indicate that the frequency of phlebotomies in PV patients on HU does not represent a risk factor for future thrombosis in PV patients and do not support the need to shift from HU plus TP to second line drugs, and indirectly reinforce that a low HCT is the key variable to reduce the thrombotic risk in PV patients

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from ECLAP and CYTO-PV clinical trials / Barbui, Tiziano; Carobbio, Alessandra; Ghirardi, Arianna; Masciulli, Arianna; Rambaldi, Alessandro; Vannucchi, Alessandro M.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - ELETTRONICO. - (2017), pp. 1-9. [10.3324/haematol.2017.165126]

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from ECLAP and CYTO-PV clinical trials

VANNUCCHI, ALESSANDRO MARIA
2017

Abstract

our results indicate that the frequency of phlebotomies in PV patients on HU does not represent a risk factor for future thrombosis in PV patients and do not support the need to shift from HU plus TP to second line drugs, and indirectly reinforce that a low HCT is the key variable to reduce the thrombotic risk in PV patients
2017
1
9
Goal 3: Good health and well-being for people
Barbui, Tiziano; Carobbio, Alessandra; Ghirardi, Arianna; Masciulli, Arianna; Rambaldi, Alessandro; Vannucchi, Alessandro M.
File in questo prodotto:
File Dimensione Formato  
BARBUI_haematol.2017.165126.full.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Creative commons
Dimensione 304.56 kB
Formato Adobe PDF
304.56 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1084432
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 21
social impact